Real-world efficacy and safety of SGLT2 inhibitor add-on triple therapy in south indian patients with type 2 diabetes mellitus: a 24-week prospective observational cohort study
{{output}}
Background: Type 2 diabetes mellitus (T2DM) in South Asian populations is characterised by early-onset disease, visceral adiposity disproportionate to body mass index, and accelerated pancreatic β-cell decline which is collectiv... ...